I joined the School of Pharmacy as a lecturer in pharmaceutics in 2011. Here I teach on the MPharm course and continue my research interest in nanomedicines. I completed my PhD in pharmaceutics at the Robert Gordon University in Aberdeen, Scotland in 2009. I

Oluwasanmi A, Malekigorji M, Jones S, Curtis A, Hoskins C. 2016. Potential of hybrid iron oxide-gold nanoparticles as thermal triggers for pancreatic cancer therapy. RSC ADVANCES, vol. 6(97), 95044-95054. link> doi> Malekigorji M, Kong Thoo Lin P, Lees M, Gueorguieva M, Curtis A, Hoskins C. 2016. 587 - Thermally triggered theranostics for pancreatic cancer. European journal of cancer (vol. 61, p. S129). Elsevier. doi> Khare V, Al Sakarchi W, Gupta PN, Curtis ADM, Hoskins C. 2016. Synthesis and characterization of TPGS-gemcitabine prodrug micelles for pancreatic cancer therapy. RSC ADVANCES, vol. 6(65), 60126-60137. link> doi> Hoskins C, Papachristou A, Ho TMH, Hine J, Curtis ADM. 2016. Investigation into drug solubilisation potential of sulfonated calix[4]resorcinarenes. Journal of Nanomedicine and Nanotechnology, vol. 7, Article 2. doi> Curtis ADM, Malekigorji M, Holman J, Skidmore M, Hoskins C. Heat Dissipation of Hybrid Iron Oxide-Gold Nanoparticles in an Agar Phantom. Journal of Nanomedicine and Nanotechnology. doi>